The latest quarterly performance of Canopy Growth Corporation (NYSE: CGC) was nothing short of a disaster, with the cannabis firm incurring a
Canopy Growth Corporation
-(CGC)
XNAS:CGC, XASX:CGC
Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results
Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens.
Canopy Growth (CGC) slips to Q3 loss; stock surges on strong revenue growth
Presenting the first quarterly report under its new CEO, Canopy Growth Corporation (NYSE: CGC) posted a net loss for the third quarter
Earnings Preview: Headwinds expected to dampen Canopy Growth’s (CGC) Q3 performance
Canadian-based major pot producer Canopy Growth (NYSE: CGC) (TSX: WEED) is poised to publish its third quarter 2020 earnings results tomorrow early morning.
Why Canopy Growth (CGC) might put investors in high spirits this year
For the cannabis industry, 2019 was a tough year though most companies started it on an optimistic note. With the year coming
Canopy Growth (NYSE: CGC) posts wider-than-expected loss in Q2
Canopy Growth (NYSE: CGC) (TSX: WEED) reported a wider loss for the second quarter of 2020 due to higher costs and expenses.
Canopy Growth (NYSE: CGC) likely to lose in Q2 earnings battle on Nov 14
Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is slated to report its second-quarter 2020 earnings results on Thursday before the market opens.
Aphria, Canopy Growth, Aurora Cannabis bow to pressure from vaping fatalities
Leading players in the cannabis industry were bleeding on Monday after the Centers for Disease Control and Prevention (CDC) revealed that it
Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0
Both Aurora Cannabis (NYSE: ACB) and Canopy Growth Corporation (NYSE: CGC) have reported disappointing quarterly results in the most recent quarter. Share
Pot giants gain on DEA announcement; GW Pharmaceuticals continues to decline
Marijuana giants received a major boost on Monday after the US Drug Enforcement Administration (DEA) announced that it would initiate steps to
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot investors. However,
Earnings: Canopy Growth posts big Q4 miss, but investors remain stoic
Canopy Growth (NYSE: CGC) reported a loss of CAD 0.98 per share on revenues of CAD 94.1 million in the fourth quarter,
Earnings preview: Will Canopy Growth post upbeat Q4 2019 results?
Canopy Growth (TSX: WEED, NYSE: CGC) is scheduled to release its financial results for the fourth fiscal quarter of 2019 after the
Calendar: Earnings of Oracle, Kroger, Canopy Growth, Red Hat, CarMax on queue
Oracle, Kroger, Canopy Growth, Red Hat, CarMax, and more earnings are scheduled for the week between June 17 and 21. Check out
Tilray stock heads downward on doubts of cannabis risks
Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. The stock has been on a downward trend since
Canopy Growth names Constellation Brands veteran as acting CFO
Image by Rex Medlen from Pixabay Shares of Canopy Growth Corporation (NYSE: CGC) gained over 2% on Tuesday after the cannabis giant
Tilray earnings preview: Investors need more than just production expansion
Though the marijuana industry has been seeing overall tremendous growth, one prominent name has been pulling it down – Tilray (NASDAQ: TLRY).
Marijuana vs US: Will Aurora Cannabis survive in the banned market?
In the US, marijuana has been slowly turning to be legal in certain states but it still remained banned at the federal
Canopy Growth accelerates US expansion plans with AgriNextUSA acquisition
The world’s largest cannabis company by market cap, Canopy Growth Corporation (CGC), on Thursday said it was acquiring US-based hemp company AgriNextUSA,
The Cannabis-beverage industry is something you don’t want to miss this year
The marijuana industry’s growth over the past couple of years has been surprising, even from a corporate level. The acceptance for cannabis-based
Tilray posts wider-than-expected Q4 loss
Tilray (TLRY) reported a wider loss in the fourth quarter due to higher operating costs and expenses. For surviving the rising competition